Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration.

Transl Vis Sci Technol · 2023 · PMC10479187 · PMID 37656449

Europe PMC DOI

hedged sentence

0.5260

closest p · 10.5× alpha

0.5260

boldest claim

The sentences

did not reach statistical significanceP = 0.526not close (p > 0.1)

For comparison between groups, there was a trend of greater numerical reduction in mean CST, mean cube thickness, and cube volume for eyes with SDD than without SDD, given the positive point estimate of the adjusted differences between groups on all three parameters; however, they did not reach statistical significance ( P = 0.526, 0.677, and 0.502, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.